We're building a better ClinicalTrials.gov. Check it out and tell us what you think!
ClinicalTrials.gov Menu

Blood and Marrow Transplant Clinical Research Network

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00023530
Recruitment Status : Completed
First Posted : September 7, 2001
Last Update Posted : February 18, 2016
Blood and Marrow Transplant Clinical Trials Network
Information provided by:
National Heart, Lung, and Blood Institute (NHLBI)

Brief Summary:
The purpose of this network is to accelerate research in hematopoietic stem cell transplantation by comparing novel therapies to existing ones.

Condition or disease Intervention/treatment Phase
Bone Marrow Transplantation Blood Disease Hematopoietic Stem Cell Transplantation Leukemia Multiple Myeloma Myelodysplastic Syndromes Graft vs Host Disease Drug: fluconazole Drug: voriconazole Procedure: bone marrow transplant Drug: thalidomide Drug: dexamethasone Not Applicable

Show Show detailed description

Layout table for study information
Study Type : Interventional  (Clinical Trial)
Allocation: Randomized
Masking: Double
Primary Purpose: Prevention
Official Title: Blood and Marrow Transplant Clinical Research Network
Study Start Date : September 2001
Actual Study Completion Date : August 2006

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.

Layout table for eligibility information
Ages Eligible for Study:   2 Years and older   (Child, Adult, Older Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Criteria for entry into a study varies by protocol

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00023530

Layout table for location information
United States, California
City of Hope National Medical Center
Duarte, California, United States, 91010
University of California at San Diego
La Jolla, California, United States, 92093
Stanford University
Palo Alto, California, United States, 94305
United States, Florida
University of Florida
Gainesville, Florida, United States, 32610
United States, Maryland
Johns Hopkins University
Baltimore, Maryland, United States, 21231
United States, Massachusetts
Dana-Farber Cancer Institute
Boston, Massachusetts, United States, 02115
United States, Michigan
University of Michigan at Ann Arbor
Ann Arbor, Michigan, United States, 48109
United States, Minnesota
University of Minnesota Twin Cities
Minneapolis, Minnesota, United States, 55455
United States, Missouri
Children's Mercy Hospital
Kansas City, Missouri, United States, 64108
United States, Nebraska
University of Nebraska Medical Center
Omaha, Nebraska, United States, 68198
United States, New York
Sloan-Kettering Institute for Cancer Research
New York, New York, United States, 10021
United States, North Carolina
Duke University
Durham, North Carolina, United States, 27705
United States, Ohio
Case Western Reserve University
Cleveland, Ohio, United States, 44106
United States, Pennsylvania
University of Pennsylvania
Philadelphia, Pennsylvania, United States, 19104
United States, Texas
MD Anderson Cancer Center
Houston, Texas, United States, 77030
United States, Washington
Fred Hutchinson Cancer Research Center
Seattle, Washington, United States, 98109
Sponsors and Collaborators
National Heart, Lung, and Blood Institute (NHLBI)
Blood and Marrow Transplant Clinical Trials Network
Layout table for investigator information
OverallOfficial: Joseph Antin Dana-Farber Cancer Institute
OverallOfficial: Frederick Appelbaum Fred Hutchinson Cancer Center
OverallOfficial: Edward Ball University of California, San Diego
OverallOfficial: James Ferrara University of Michigan at Ann Arbor
OverallOfficial: Stephen Forman City of Hope National Medical Center
OverallOfficial: Alan Gamis Children's Mercy Hospital Kansas City
OverallOfficial: Sergio Giralt M.D. Anderson Cancer Center
OverallOfficial: Mary Horowitz Medical College of Wisconsin
OverallOfficial: Richard Jones Johns Hopkins University
OverallOfficial: Joanne Kurtzberg Duke University
OverallOfficial: Gina Laport Stanford University
OverallOfficial: Hillard Lazarus Case Western Reserve University
OverallOfficial: Richard O'Reilly Sloan-Kettering Institute for Cancer Research
OverallOfficial: Edward Stadtmauer University of Pennsylvania
OverallOfficial: Julie Vose University of Nebraska
OverallOfficial: Daniel Weisdorf University of Minnesota
OverallOfficial: John Wingard University of Florida
Layout table for additonal information
ClinicalTrials.gov Identifier: NCT00023530    
Other Study ID Numbers: 139
U01HL069301 ( U.S. NIH Grant/Contract )
First Posted: September 7, 2001    Key Record Dates
Last Update Posted: February 18, 2016
Last Verified: July 2006
Additional relevant MeSH terms:
Layout table for MeSH terms
Multiple Myeloma
Myelodysplastic Syndromes
Hematologic Diseases
Graft vs Host Disease
Neoplasms, Plasma Cell
Neoplasms by Histologic Type
Hemostatic Disorders
Vascular Diseases
Cardiovascular Diseases
Blood Protein Disorders
Hemorrhagic Disorders
Lymphoproliferative Disorders
Immunoproliferative Disorders
Immune System Diseases
Bone Marrow Diseases
Anti-Inflammatory Agents
Autonomic Agents
Peripheral Nervous System Agents
Physiological Effects of Drugs
Gastrointestinal Agents
Hormones, Hormone Substitutes, and Hormone Antagonists